Corona crisis increases cannabis demand

cannabis demand increases due to Corona
Written by Dennis Mattern

While Covid-19 continues to rampage the global economy, it has created an enormous advantage for the cannabis market. Thanks to the corona crisis, the cannabis industry’s sales volume has grown significantly.

The fact that cannabis will ever be as popular as flour and sugar is rather hard to imagine. Despite the lockdown, medical cannabis shops were allowed to remain open in most US states, as they are considered essential parts of the health care system. Other recreational cannabis shops were allowed to remain open at least for delivery and pick-up.

According to industry analyst Stephen Murphy, founder of the cannabis analysis house Probition Partners, it is a good sign why cannabis has been classified as a “necessary” good by some US states. He says

This shows how embedded cannabis is in the core of society.

Investments will become tougher

While the industry as such is not affected by the corona crisis in the cannabis segment, the financing sector is.  Many investors have already become more careful.

Consequently, it will become more difficult for companies to secure venture capital in the near future. Some companies have already stopped their expansion plans, cut jobs or had to close down completely, which has also cost investors money.  Yet the industry still needs a lot of money for lobbying, machinery, technology and employees.

Equally, it is important to bear in mind that the cannabis industry continues to struggle with stigma.  The 2018 Canadian release has been rather slow so far and has been a frustration for the industry. So far, the big boom has failed to happen.

Corona crisis ensures economic recovery

Compared to previous months, the nascent British market for cannabidiol products (CBD) has reported an increase in demand since the beginning of the corona crisis. More than 8 million Britains now buy CBD products. In the first four months of 2020 alone, more than 150 million pounds sterling were purchased. This puts the market on track for a full year revenue target of £450 million, which would represent a 50% growth compared to 2019.

The only remaining question is whether the increased interest in CBD products in the UK will continue beyond the current crisis.

Did you like this article?

Click on a star to rate!

Average rating / 5. Number of ratings:

No rating yet! Give the first vote.

About the author

Dennis Mattern

Dennis Mattern

Dennis is an essential part of the CannaTrust team. He has been with us since day 1 and is COO and Account Manager for CannaTrust. He himself has already gained many personal experiences with CBD. Several members of his family use cannabinoid products for their chronic diseases.